Optas, LLC Takeda Pharmaceutical CO LTD Transaction History

Optas, LLC

$574 Million
Q3 2025

A detailed history of Optas, LLC transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Optas, LLC holds 11,254 shares of TAK stock, worth $156,205. This represents 0.03% of its overall portfolio holdings.

Number of Shares

11,254

Holding current value

$156,205

% of portfolio

0.03%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2025 Oct 15, 2025	BUY	$13.6 - $15.52 $153,054 - $174,662	11,254 New	11,254 $164,000
Q3 2023 Oct 31, 2023	BUY	$15.03 - $16.32 $152,674 - $165,778	10,158 New	10,158 $157,000

Others Institutions Holding TAK

# of Institutions

368

Shares Held

73.1M

Call Options Held

1.68M

Put Options Held

157K

Capital Research Global Investors Los Angeles, CA

13.3M
Shares

$185 Million
0.04% of portfolio
Morgan Stanley New York, NY

7.62M
Shares

$106 Million
0.01% of portfolio
Goldman Sachs Group Inc New York, NY

4.5M
Shares

$62.5 Million
0.01% of portfolio
Ubs Group Ag

4.02M
Shares

$55.9 Million
0.01% of portfolio
Brandes Investment Partners, LP La Jolla, CA

3.71M
Shares

$51.5 Million
0.54% of portfolio

View Full List

About TAKEDA PHARMACEUTICAL CO LTD

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $43.2B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

More about TAK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Optas, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Optas, LLC with notifications on news.

Account